Technetium-99m-medronate uptake in hepatic necrosis associated with Budd-Chiari syndrome.
A 99mTc-MDP bone scan performed on a 52-yr-old female for possible bone metastasis revealed prominent hepatic uptake. Subsequently, a 99mTc-SC scan revealed tracer uptake in the caudate lobe with diminished uptake in the remainder of the liver. Further imaging with Doppler ultrasound and hepatic venography confirmed a diagnosis of Budd-Chiari syndrome. Hepatic necrosis, demonstrated on CT imaging, was secondary to Budd-Chiari syndrome and was felt to be the cause of 99mTc-MDP hepatic uptake in this patient.
Parker
G E
GE
Department of Radiology, Medical College of Virginia, Virginia Commonwealth University, Richmond.
Burke
T S
TS
D006502:Budd-Chiari Syndrome / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism / Q000473:pathology*; D008875:Middle Aged; D009336:Necrosis; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate / Q000493:pharmacokinetics*
D013669:Technetium Tc 99m Medronate